Life Sciences & Health Care
The Life Sciences and Health Care sector is facing a wide range of major challenges driven by the need to protect current earnings, transform business models (to do more with less) and grow new businesses in related areas.
Ongoing challenges include: patent expiration, pressure on pricing from generics and greater focus on comparative effectiveness, increasing attention on enforcement of regulations, new healthcare laws and regulations, fraud and counterfeit, privacy and security and risks associated with diversification into related businesses (e.g., consumer, branded generics and medical devices). Strengthening risk management capabilities and building organization resilience are essential during a period of major change.
Relevant ERS propositions for the Life Sciences & Health Care industry
- Global Privacy Compliance
- Sustainability Compliance, Reporting & Assurance
- Regulatory Risk Solutions
Contact Information
Stay connected
Material on this website is © 2013 Deloitte Global Services Limited, or a member firm of Deloitte Touche Tohmatsu Limited, or one of their affiliates. See Legal for copyright and other legal information.
Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee, and its network of member firms, each of which is a legally separate and independent entity. Please see www.deloitte.com/about for a detailed description of the legal structure of Deloitte Touche Tohmatsu Limited and its member firms.